-
Quality assessment of clinical practice guidelines for eosinophilic esophagit...
Background: High-quality evidence-based clinical practice guidelines can guide diagnosis and treatment to optimize outcomes. We aimed to systematically review the quality of... -
Chronic use of statins and risk of post-endoscopic retrograde cholangiopancre...
There is limited evidence on the role of chronic statin therapy in the prevention of acute pancreatitis after ERCP. The aim of this meta-analysis was to evaluate the efficacy of... -
Management of gastrointestinal complications in hereditary transthyretin amyl...
Introduction: Hereditary transthyretin amyloidosis (ATTRm amyloidosis) is a rare disease caused by the deposition and accumulation of insoluble non-native transthyretin fibrils... -
dedup_wf_001--25553a06e3b640feaadea6a3386c84c7
The occurrence of perineal fistula is a significant evesnt in the evolution of Crohn’s disease. Approximately 21% to 23% of patients develop perineal fistula at least once in... -
Dientamoeba fragilis in children: a systematic review on diagnostic considera...
Introduction: The presence of D. fragilis in feces is characterized by an asymptomatic carrier ship to a spectrum of gastrointestinal symptoms. However, a causal relationship... -
Cost-effectiveness analysis of therapeutic options for chronic hepatitis C ge...
Background: This study provides a cost-effectiveness analysis of therapeutic strategies for chronic hepatitis C genotype 3 infected patients in Spain. Methods: A Markov model... -
Somatostatin analogue-induced pancreatic exocrine insufficiency in patients w...
Background: Patients with advanced well-differentiated neuroendocrine tumours (Wd-NETs) are commonly treated with somatostatin analogues (SSAs). Some patients may develop... -
Safety and tolerability of linaclotide for the treatment of chronic idiopathi...
Background: Linaclotide is approved for treating irritable bowel syndrome with constipation (IBS-C; 290 µg QD) and chronic idiopathic constipation (CIC; 145 µg or 72 µg QD)....